Author/Authors :
Simon، نويسنده , , Teresa A and Gelarden، نويسنده , , R.Thomas and Freitag، نويسنده , , Steven A and Kassler-Taub، نويسنده , , Kenneth B and Davies، نويسنده , , Richard، نويسنده ,
Abstract :
Nine multicenter, randomized, placebo-controlled studies were conducted to evaluate the safety and tolerability of the angiotensin II subtype 1 receptor blocker (AT1 blocker) irbesartan for the treatment of mild to moderate hypertension. After a 4- to 5-w
